Will side effects continue after stopping semaglutide
Date : DMF Number : 43330 Submission : 2025-12-24 Status : Active Type : II USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others Biosynergy Pharmaceutical is a manufacturer of APIs, intermediates, and specialty chemicals for global pharmaceutical markets
Individual weight loss on Semaglutide will be dictated by several factors, including adherence to the prescribed treatment schedule, the consistency of dosage escalation, the patients starting weight, and their commitment to accompanying health and lifestyle changes (particularly dietary modification and regular physical activity)
However, the long-term benefits of improved glycemic control, weight reduction, and potential cardiovascular benefits may justify the investment in semaglutide for many patients